[1]Wu T, Pinto HB, Kamikawa YF, et al. The BET family member BRD4 interacts with OCT4 and regulates pluripotency gene expression [J]. Stem Cell Rep, 2015, 4(3): 390-403.
[2]Schnepp RW, Maris JM. Targeting MYCN: a good BET for improving neuroblastoma therapy [J]. Cancer Discov, 2013, 3(3): 255-257.
[3]Tian B, Hosoki K, Liu ZQ, et al. Mucosal bromodomain-containing protein 4 mediates aeroallergen-induced inflammation and remodeling [J]. J Allergy Clin Immunol, 2019, 143(4):1380-1394.
[4]Andrieu GP, Shafran JS, Deeney JT, et al. BET proteins in abnormal metabolism, inflammation, and the breast cancer microenvironment [J]. J Leukoc Biol, 2018, 104(2): 265-274.
[5]White ME, Fenger JM, Carson WE. Emerging roles of and therapeutic strategies targeting BRD4 in cancer [J]. Cell Immunol, 2019, 337: 48-53.
[6]Filippakopoulos P, Qi J, Picaud S, et al. Selective inhibition of BET bromodomains [J]. Nature, 2010, 468(7327): 1067-1073.
[7]Leal AS, Williams CR, Royce DB, et al. Bromodomain inhibitors, JQ1 and I-BET 762, as potential therapies for pancreatic cancer [J]. Cancer Lett, 2017, 394: 76-87.
[8]Park S, Willingham MC, Qi J, et al. Metformin and JQ1 synergistically inhibit obesity-activated thyroid cancer [J]. Endocr Relat Cancer, 2018, 25(10): 865-877.
[9]Judith SV, Jesús AA, Xavier N, et al. BET protein inhibition regulates cytokine production and promotes neuroprotection after spinal cord injury [J]. J Neuroinflamm ation, 2019, 16(1): 124.
[10] Machado NJ, Sim?es AP, Silva HB, et al. Caffeine reverts memory but not mood impairment in a depression-prone mouse strain with up-regulated adenosine A 2A receptor in hippocampal glutamate synapses [J]. Mol Neurobiol, 2017, 54(2): 1552-1563.
[11] Hu XD, Ballo L, Pietila L, et al. BDNF-induced increase of PSD-95 in dendritic spines requires dynamic microtubule invasions [J]. J Neurosci, 2011, 31(43): 15597-15603.
[12] Erica K, Herre M, Ilana ZS, et al. BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice [J]. Nat Neurosci, 2015, 18(10): 1464-1473.
[13] Yaster M, Guan X, Petralia RS, et al. Effect of inhibition of spinal cord glutamate transporters on inflammatory pain induced by Formaldehyde solution and complete Freund’s adjuvant [J]. Anesthesiology, 2011, 114(2): 412-423.
[14] Hough LB, Rice FL. H3 receptors and pain modulation: peripheral, spinal, and brain interactions [J]. J Pharmacol Exp Ther, 2011, 336(1): 30-37.
[15] Bandopadhayay P, Bergthold G, Nguyen B, et al. BET bromodomain inhibition of MYC-amplified medulloblastoma [J]. Clin Cancer Res, 2014, 20(4): 912-925.
[16] Korb E, Herre M, Zucker SI, et al. BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice [J]. Nat Neurosci, 2015, 18(10): 1464-1473.
[17] Mele DA, Salmeron A, Ghosh S, et al. BET bromodomain inhibition suppresses TH17-mediated pathology [J]. J Exp Med, 2013, 210(11): 2181-2190.
[18] Jung KH, Das A, Chai JC, et al. RNA sequencing reveals distinct mechanisms underlying BET inhibitor JQ1-mediated modulation of the LPS-induced activation of BV-2 microglial cells [J]. J Neuroinflammation, 2015, 12: 36.
[19] Sartor GC, Powell SK, Brothers SP, et al. Epigenetic readers of lysine acetylation regulate cocaine-induced plasticity [J]. J Neurosci, 2015, 35(45): 15062-15072.
[20] Hsieh MC, Ho YC, Lai CY, et al. Bromodomain-containing protein 4 activates voltage-gated sodium channel 1.7 transcription in dorsal root ganglia neurons to mediate thermal hyperalgesia in rats [J]. Anesthesiology, 2017, 127(5): 862-877.
[21] Takahashi K, Yi H, Liu CH, et al. Spinal bromodomain-containing protein 4 contributes to neuropathic pain induced by HIV glycoprotein 120 with morphine in rats [J]. Neuroreport, 2018, 29(6): 441-446.
[22] Guerra B, Issinger OG. Protein kinase CK2 in human diseases [J]. Curr Med Chem, 2008, 15(19): 1870-1886.
|